JIA subtype distribution varied by treatment group: undifferentiated and oligoarthritis predominated in the MTX group, extended oligoarthritis in the TNF inhibitor group, and RF-negative polyarthritis in the combination group. This evidence concerns the gene TNF and juvenile idiopathic arthritis.